인터페론 투여 후 완전 절제를 시행한 거대 선천성 간내 혈관내피종
A Congenital Giant Hepatic Hemangioendothelioma Treated with Interferon-α and Complete Tumor Resection
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Infantile hepatic hemangioendotheliomas (IHHEs) are benign vascular tumors, but can be associated with the life-threatening complications, such as congestive heart failure, disseminated intravascular coagulation, and massive bleeding. Various therapeutic options have been developed and the treatment response depends on the patient's clinical status and the nature of the lesion. In the case of a symptomatic IHHE, a non-invasive and precise diagnosis should be performed promptly before the therapeutic method is chosen. Additionally, it should be kept in mind that the residual lesions have malignant potential. We report a case of a congenital giant IHHE that was successfully reduced in size by interferon-α and completely removed by surgical tumor resection with a hepatic lobectomy.
Abstract
Infantile hepatic hemangioendotheliomas (IHHEs) are benign vascular tumors, but can be associated with the life-threatening complications, such as congestive heart failure, disseminated intravascular coagulation, and massive bleeding. Various therapeutic options have been developed and the treatment response depends on the patient's clinical status and the nature of the lesion. In the case of a symptomatic IHHE, a non-invasive and precise diagnosis should be performed promptly before the therapeutic method is chosen. Additionally, it should be kept in mind that the residual lesions have malignant potential. We report a case of a congenital giant IHHE that was successfully reduced in size by interferon-α and completely removed by surgical tumor resection with a hepatic lobectomy.
참고문헌 (20)
- Isaacs H Jr, "Fetal and neonatal hepatic tumors", J Pediatr Surg, 42, pp.1797~1803 (2007)
- Koch M, "Malignant tumors of blood vessels: angiosarcomas, hemangioendotheliomas, and hemangiopericytomas", J Surg Oncol, 97, pp.321~329 (2008)
- Daller JA, "Hepatic hemangioendothelioma: clinical experience and management strategy", J Pediatr Surg, 34, pp.98~105 (1999)
- Warmann S, "Hausdorf G, Fuchs J. Interventional treatment of infantile hepatic hemangioendothelioma", J Pediatr Surg, 38, pp.1177~1181 (2003)
- Sevınır B, "Infantile hepatic hemangioendothelioma: clinical presentation and treatment", Turk J Gastroenterol, 18, pp.182~187 (2007)
- North PE, "Vascular tumors of infancy and childhood: beyond capillary hemangioma", Cardiovasc Pathol, 15, pp.303~317 (2006)
- Jung HJ, "Giant neonatal hemangioendothelioma of the liver diagnosed by 99mTc-RBC scintigraphy", J Korean Soc Neonatol, 12, pp.105~111 (2005)
- Sari N, "Infantile hepatic hemangioendothelioma with elevated serum alpha-fetoprotein", Pediatr Hematol Oncol, 23, pp.639~647 (2006)
- Jo HJ, "Infantile hemangioendothelioma of the liver. Brief case report", Korean J Pathol, 31, pp.586~588 (1997)
- Nord KM, "Multiple cutaneous infantile hemangiomas associated with hepatic angiosarcoma: case report and review of the literature", Pediatrics, 118, pp.e907~e913 (2006)
- Park EA, "Infantile hemangioendothelioma treated with high dose methylprednisolone pulse therapy", J Korean Med Sci, 16, pp.127~129 (2001)
- Meirowitz NB, "Hepatic hemangioendothelioma: prenatal sonographic findings and evolution of the lesion", J Clin Ultrasound, 28, pp.258~263 (2000)
- Cerar A, "Infantile hemangioendothelioma of the liver in a neonate. Immunohistochemical observations", Am J Surg Pathol, 20, pp.871~876 (1996)
- MortelKJ, "Solitary hepatic infantile hemangioendothelioma: dynamic gadolinium-enhanced MR imaging findings", Eur Radiol, 12, pp.862~865 (2002)
- Wu JT, "Serum alpha fetoprotein (AFP) levels in normal infants", Pediatr Res, 15, pp.50~52 (1981)
- Deb G, "Hemangioendothelioma: successful therapy with interferon-alpha: a study in Association with the Italian Pediatric Haematology", Oncology Society (AIEOP), 2002, pp.38, 118~119
- Woltering MC, "Hepatic hemangioendothelioma of infancy: treatment with interferon alpha", J Pediatr Gastroenterol Nutr, 24, pp.348~351 (1997)
- Ferrantini M, "Interferonalpha and cancer: mechanisms of action and new perspectives of clinical use", Biochimie, 89, pp.884~893 (2007)
- de la Hunt MN, "Kasabach-Merritt syndrome: dangers of interferon and successful treatment with pentoxifylline", J Pediatr Surg, 41, pp.e29~e31 (2006)
- Barlow CF, "Spastic diplegia as a complication of interferon Alfa-2a treatment of hemangiomas of infancy", J Pediatr, 132, pp.527~530 (1998)